Home » Blogs » Page 21

Lupin Ltd. stock analysis & expert insights in detail

Can Lupin sustain its turnaround momentum through strong U.S. launches, steady India growth, and margin recovery to reaffirm its position among leading pharma players? Let’s find out!

After years of volatility driven by regulatory challenges, pricing pressures, and delayed launches, Lupin Ltd has made a strong comeback. With improving margins, a...